Sharon Bakalash
CEO
Claimed by owner OphRx
Former names:
Noninvasive Drug-delivery Technology for Ocular Use
OphRx
www.prnewswire.com
•
Jul 24, 2017
BioLight Reports Successful Results in Phase 1/2a Clinical Trial for Glaucoma Insert
www.israel21c.org
•
Apr 18, 2016
When size matters: Tiny innovations for a better world
www.globes.co.il
•
Mar 22, 2016
Conference to showcase Hebrew University nanotech
www.prnewswire.com
•
Dec 21, 2015
Bio Light's IOPtiMate[TM] System Receives Regulatory Approval in Canada
About
OphRx is developing eye drops based on noninvasive drug delivery that utilize lyotropic liquid crystals as an alternative to current delivery modalities, such as intra-vitreal injections, used to treat diseases at the back of the eye. This platform technology can also be used for front-of-the-eye treatments.
OphRx is currently in the preclinical stage of development of two product candidates: OPH-101, an alternative topical treatment to intravitreal injections for wet AMD; and OPH-100, a treatment for DES.
OphRx is a XLVision Sciences company, which is fully owned by BioLight Life Sciences Investments.
OphRx is currently in the preclinical stage of development of two product candidates: OPH-101, an alternative topical treatment to intravitreal injections for wet AMD; and OPH-100, a treatment for DES.
OphRx is a XLVision Sciences company, which is fully owned by BioLight Life Sciences Investments.
Employees
Product stage
Primary Sector
Life Sciences & HealthTech
Products
OPH-101, OPH-100
Geographic markets
Global
News
(4)
www.prnewswire.com
•
Jul 24, 2017
BioLight Reports Successful Results in Phase 1/2a Clinical Trial for Glaucoma Insert
www.israel21c.org
•
Apr 18, 2016
When size matters: Tiny innovations for a better world
www.globes.co.il
•
Mar 22, 2016
Conference to showcase Hebrew University nanotech
www.prnewswire.com
•
Dec 21, 2015
Bio Light's IOPtiMate[TM] System Receives Regulatory Approval in Canada
The Team
(3)
SB
IB
Itai Bar-Natan
CFO @ Bio Light
RD
Robert David
Chief Medical Officer
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Company Lifecycle
Private Equity Funding
Seed
$1M
Jan 2014
4 Investors
$1M
Others
Academic Techonology
Jun 2015
undefined
Noninvasive Drug-delivery Technology for Ocular Use
Media gallery
(0)Locations
Israel
Kiryat Atidim, Tel Aviv-Yafo, Israel
Locations
Israel
Kiryat Atidim, Tel Aviv-Yafo, Israel
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,